icon-folder.gif   Conference Reports for NATAP  
 
  EASL 47th Annual Meeting
April 18th - 22nd 2012
Barcelona, Spain
Back grey_arrow_rt.gif
 
 
 
TMC435 in patients infected with HCV genotype 1 who have failed previous pegylated interferon / ribavirin treatment: Virologic analyses of the ASPIRE trial
 
 
  Reported by Jules Levin
EASL 2012 April18-22 Barcelona Spain
 
Oliver Lenz,1Bart Fevery,1Leen Vijgen,1Jannick Verbeeck,1Monika Peeters,1Maria Beumont-Mauviel,1Stefan Zeuzem,2Gaston Picchio3 1Janssen Infectious Diseases BVBA, Beerse, Belgium; 2Department of Medicine I, JW Goethe University Hospital, Frankfurt, Germany; 3Janssen Research and Development LLC, Titusville, NJ, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif